These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37883667)

  • 21. Characteristics of Adults Aged ≥18 Years Evaluated for Substance Use and Treatment Planning - United States, 2019.
    Kacha-Ochana A; Jones CM; Green JL; Dunphy C; Govoni TD; Robbins RS; Guy GP
    MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(23):749-756. PubMed ID: 35679167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.
    Wu LT; McNeely J; Subramaniam GA; Brady KT; Sharma G; VanVeldhuisen P; Zhu H; Schwartz RP
    Drug Alcohol Depend; 2017 Oct; 179():42-46. PubMed ID: 28753480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The latent class structure of substance use in US adults 50 years and older.
    Schepis TS; McCabe SE
    Int J Geriatr Psychiatry; 2021 Dec; 36(12):1867-1877. PubMed ID: 34318511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription-, Illicit-, and Self-Harm Opioid Overdose Cases Treated in Hospital.
    Conner KR; Wiegand TJ; Kaukeinen K; Gorodetsky R; Schult R; Heavey SC
    J Stud Alcohol Drugs; 2018 Nov; 79(6):893-898. PubMed ID: 30573020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of race, gender, and heroin use on opioid addiction stigma.
    Goodyear K; Ahluwalia J; Chavanne D
    J Subst Abuse Treat; 2022 Dec; 143():108872. PubMed ID: 36115273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceived stigma and social support in treatment for pharmaceutical opioid dependence.
    Cooper S; Campbell G; Larance B; Murnion B; Nielsen S
    Drug Alcohol Rev; 2018 Feb; 37(2):262-272. PubMed ID: 28884866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008-2009.
    Johnson EM; Lanier WA; Merrill RM; Crook J; Porucznik CA; Rolfs RT; Sauer B
    J Gen Intern Med; 2013 Apr; 28(4):522-9. PubMed ID: 23070654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance Use Stigma and Community Drug Checking: A Qualitative Study Examining Barriers and Possible Responses.
    Davis S; Wallace B; Van Roode T; Hore D
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Portraying mental illness and drug addiction as treatable health conditions: effects of a randomized experiment on stigma and discrimination.
    McGinty EE; Goldman HH; Pescosolido B; Barry CL
    Soc Sci Med; 2015 Feb; 126():73-85. PubMed ID: 25528557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stigma and the public health agenda for the opioid crisis in America.
    Corrigan PW; Nieweglowski K
    Int J Drug Policy; 2018 Sep; 59():44-49. PubMed ID: 29986271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription opioid misuse and comorbid substance use: Past 30-day prevalence, correlates and co-occurring behavioral indicators in the 2016 National Survey on Drug Use and Health.
    Grigsby TJ; Howard JT
    Am J Addict; 2019 Feb; 28(2):111-118. PubMed ID: 30701620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signals of increasing co-use of stimulants and opioids from online drug forum data.
    Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
    Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription drug and alcohol simultaneous co-ingestion in U.S. young adults: Prevalence and correlates.
    Schepis TS; McCabe SE; Ford JA
    Exp Clin Psychopharmacol; 2022 Dec; 30(6):797-808. PubMed ID: 34410796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The United States opioid epidemic.
    Lyden J; Binswanger IA
    Semin Perinatol; 2019 Apr; 43(3):123-131. PubMed ID: 30711195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mental health consequences of nonmedical prescription drug use among adolescents.
    Ali MM; Dean D; Lipari R; Dowd WN; Aldridge AP; Novak SP
    J Ment Health Policy Econ; 2015 Mar; 18(1):3-15. PubMed ID: 25862204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol and illegal drug use behaviors and prescription opioids use: how do nonmedical and medical users compare, and does motive to use really matter?
    Ghandour LA; El Sayed DS; Martins SS
    Eur Addict Res; 2013; 19(4):202-10. PubMed ID: 23391856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stigma and substance use disorders: an international phenomenon.
    Yang LH; Wong LY; Grivel MM; Hasin DS
    Curr Opin Psychiatry; 2017 Sep; 30(5):378-388. PubMed ID: 28700360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance use, substance use disorders, and treatment in adolescent and young adult cancer survivors-Results from a national survey.
    Ji X; Cummings JR; Mertens AC; Wen H; Effinger KE
    Cancer; 2021 Sep; 127(17):3223-3231. PubMed ID: 33974717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.